The human KRAS gene, located on chromosome 12.p12.1, is the most common oncogenic driver, with G12C representing the most frequent mutation in NSCLC, followed by G12V, G12D, and G12A. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.